IL315802A - Liquid formulations of ivermectin compositions and use in gelatin dosage forms - Google Patents

Liquid formulations of ivermectin compositions and use in gelatin dosage forms

Info

Publication number
IL315802A
IL315802A IL315802A IL31580224A IL315802A IL 315802 A IL315802 A IL 315802A IL 315802 A IL315802 A IL 315802A IL 31580224 A IL31580224 A IL 31580224A IL 315802 A IL315802 A IL 315802A
Authority
IL
Israel
Prior art keywords
dosage forms
liquid formulations
gelatin dosage
ivermectin
compositions
Prior art date
Application number
IL315802A
Other languages
Hebrew (he)
Original Assignee
L4 Bio Llc
Catalent Pharma Solutions Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L4 Bio Llc, Catalent Pharma Solutions Llc filed Critical L4 Bio Llc
Publication of IL315802A publication Critical patent/IL315802A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL315802A 2022-03-22 2023-03-22 Liquid formulations of ivermectin compositions and use in gelatin dosage forms IL315802A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263322267P 2022-03-22 2022-03-22
PCT/US2023/064796 WO2023183831A1 (en) 2022-03-22 2023-03-22 Liquid formulations of ivermectin compositions and use in gelatin dosage forms

Publications (1)

Publication Number Publication Date
IL315802A true IL315802A (en) 2024-11-01

Family

ID=88102199

Family Applications (1)

Application Number Title Priority Date Filing Date
IL315802A IL315802A (en) 2022-03-22 2023-03-22 Liquid formulations of ivermectin compositions and use in gelatin dosage forms

Country Status (7)

Country Link
US (1) US20250195551A1 (en)
EP (1) EP4496576A4 (en)
JP (1) JP2025512795A (en)
CN (1) CN119255808A (en)
CA (1) CA3246159A1 (en)
IL (1) IL315802A (en)
WO (1) WO2023183831A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016201743B2 (en) * 2010-05-12 2017-10-19 Boehringer Ingelheim Animal Health USA Inc. Injectable parasiticidal formulations of levamisole and macrocyclic lactones
PL3172964T3 (en) * 2011-09-12 2021-03-08 Boehringer Ingelheim Animal Health USA Inc. Antiparasitic compositions containing an isoxazoline active ingredient, method and uses thereof
NZ630169A (en) * 2013-02-27 2017-07-28 Laurie Robert Batt Anhydrous transdermal formulations
CN104706584A (en) * 2013-12-16 2015-06-17 天津迈迪瑞康生物医药科技有限公司 Ivermectin fat emulsion concentrated solution, preparation method and application thereof
WO2021138564A1 (en) * 2019-12-31 2021-07-08 Cure Pharmaceutical Holding Corp. Oral dissolvable film and method of manufacturing and using the same
CN115361944A (en) * 2020-01-10 2022-11-18 均衡生物制药私人有限责任公司 Treatment of neurological disorders with avermectins
US11077134B1 (en) * 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes

Also Published As

Publication number Publication date
WO2023183831A1 (en) 2023-09-28
CN119255808A (en) 2025-01-03
JP2025512795A (en) 2025-04-22
EP4496576A1 (en) 2025-01-29
CA3246159A1 (en) 2023-09-28
EP4496576A4 (en) 2026-03-11
US20250195551A1 (en) 2025-06-19

Similar Documents

Publication Publication Date Title
AR026916A1 (en) PHARMACEUTICAL COMBINATIONS AND THEIR USE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS
UA102478C2 (en) Capsule composition
DK1368004T3 (en) Mucoadhesive dispersible pharmaceutical preparation for administration of active agent in veterinary and human medicine
NO20030897L (en) Process for the preparation of pharmaceutical compositions for use with wet gelatin formulations
IL316049A (en) Pharmaceutical compositions of mosunetuzumab and methods of use
IL316170A (en) Pharmaceutical compositions of therapeutic proteins and methods of use
ES2865254T3 (en) Compositions for the treatment of atrophic vaginitis, perimenopausal and postmenopausal dyspareunia and / or oophorectomized women and methods of treatment therewith
ZA202213412B (en) Pharmaceutical compositions containing enterokine-releasing substances in multiple dosage forms in combination with gelling agents
IL315802A (en) Liquid formulations of ivermectin compositions and use in gelatin dosage forms
IL272036B1 (en) Methods and compositions for treating pain using capsaicin
AR048806A1 (en) USE OF CARIOFILENES IN THE PREPARATION OF MEDICINES AND TREATMENT OF BODY INFLAMMATION AND INFLAMMATORY PAIN AFFECTIONS
JP7186024B2 (en) External pharmaceutical composition
EP4297777A4 (en) Oral compositions and use of same in vaccination
Sahu et al. Formulation and Characterization of Resorcinol Gel
IL326143A (en) Use of wuling formulation in the preparation of drug for preventing or treating non-alcoholic fatty liver disease
GB2626266B (en) Oral pharmaceutical compositions of progesterone and estradiol
TR200201556A2 (en) Pharmaceutical composition containing corticosteroids and nonsteroidal anti-inflammatory
PL4401743T3 (en) COMPOSITION CONTAINING SODIUM HYALURONATE AND AMINO ACIDS FOR USE IN THE FIELD OF ORTHOPEDICS
WO2020044114A3 (en) Methotrexate pharmaceutical composition
ES3064824T3 (en) Pharmaceutical formulations of bictegravir and lenacapavir
EP3856148A4 (en) PHARMACEUTICAL FORMULATION CONTAINING A TRIGLYCERIDE SELENITE AND A CYTOSTATIC AGENT FOR USE IN THE TREATMENT OF A TUMOR
More et al. An Overview on Antifungal Drug Therapy
GB202408903D0 (en) Pharmaceutical compositions and medical uses
Hekmatian et al. Evaluation of the effect of Elaeagnus angustifolia drug film on gag reflex.
IL314496A (en) Pharmaceutical composition of anti-trbv9 antibody and use thereof